Medication info
Besilsartan Tablets 5/50 mg (Amlodipine, Losartan Potassium)

Besilsartan Tablets 5/50 mg (Amlodipine, Losartan Potassium)

Prescription medicationTabletOral
Ingredient · strength
Amlodipine Besylate›6.944mg / 1 tabletLosartan Potassium›50mg / 1 tablet
Manufacturer / importer
Huons Co., Ltd.
Appearance
White rectangular film-coated tablets
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 201502639 · Approved 2015.04.30 · Insurance code 670607250

Summary

Main use
Control of essential hypertension; initial treatment of stage 2 hypertension
Who takes it
Adults · Children
Adult dose
The recommended dose is 1 tablet once daily, taken with water, with or without food. It is recommended that the tablet be taken at the same time each day, if possible (e.g., in the morning). Before treatment with this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or losartan). However, if blood pressure is not controlled with monotherapy using the individual components as described below, switching directly to this medicine may be considered. - 5/50 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or losartan 50 mg monotherapy. - 5/100 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or losartan 100 mg monotherapy. Patients taking amlodipine and losartan concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Before administering this medicine as initial therapy to patients with stage 2 hypertension, the decision to administer it should take into account baseline blood pressure, target blood pressure, and the expected likelihood of reaching the treatment goal with the combination compared with monotherapy. The usual dose is 5/50 mg once daily. If blood pressure is not adequately controlled after 2 weeks of treatment, the dose may be increased to 10/50 mg once daily. ○ Patients with renal impairment: No dose adjustment is necessary in patients with mild renal impairment (e.g., creatinine clearance 20∼50 mL/min); however, use of this medicine is not recommended in patients with moderate to severe renal impairment (e.g., creatinine clearance < 20 mL/min) or in patients undergoing dialysis. ○ Patients with reduced intravascular volume: Use of this medicine is not recommended in a small number of patients with reduced intravascular volume (e.g., patients receiving high doses of diuretics). (See Section 1, Warnings, under Precautions for Use.) ○ Patients with hepatic impairment: Use of this medicine is not recommended in patients with a history of hepatic impairment who require a reduced dose of losartan (e.g., 25 mg once daily). ○ Older adults: In older adults aged 75 years or older, an initial dose of losartan of 25 mg once daily is recommended; therefore, use of this medicine as initial therapy is not recommended.
Child dose
○ Children: The safety and efficacy of this medicine have not been established in pediatric patients aged 18 years or younger; therefore, its use is not recommended.

Ingredients

Manufacturer
Huons Co., Ltd.

Efficacy & effects

Control of essential hypertension; initial treatment of stage 2 hypertension

  • Essential hypertension
  • stage 2 hypertension
View approved original text

For patients with essential hypertension who have difficulty controlling blood pressure with monotherapy alone, the combination of amlodipine and losartan can effectively manage blood pressure. Additionally, this medication is suitable for stage 2 hypertension patients who require combination therapy from the start to reach the target blood pressure. This combination aids in more stable control of blood pressure, helping to reduce the risk of cardiovascular diseases. Therefore, this medication is effectively used in the treatment of hypertension.

How to take

Adult dose

The recommended dose is 1 tablet once daily, taken with water, with or without food. It is recommended that the tablet be taken at the same time each day, if possible (e.g., in the morning). Before treatment with this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or losartan). However, if blood pressure is not controlled with monotherapy using the individual components as described below, switching directly to this medicine may be considered. - 5/50 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or losartan 50 mg monotherapy. - 5/100 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or losartan 100 mg monotherapy. Patients taking amlodipine and losartan concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Before administering this medicine as initial therapy to patients with stage 2 hypertension, the decision to administer it should take into account baseline blood pressure, target blood pressure, and the expected likelihood of reaching the treatment goal with the combination compared with monotherapy. The usual dose is 5/50 mg once daily. If blood pressure is not adequately controlled after 2 weeks of treatment, the dose may be increased to 10/50 mg once daily. ○ Patients with renal impairment: No dose adjustment is necessary in patients with mild renal impairment (e.g., creatinine clearance 20∼50 mL/min); however, use of this medicine is not recommended in patients with moderate to severe renal impairment (e.g., creatinine clearance < 20 mL/min) or in patients undergoing dialysis. ○ Patients with reduced intravascular volume: Use of this medicine is not recommended in a small number of patients with reduced intravascular volume (e.g., patients receiving high doses of diuretics). (See Section 1, Warnings, under Precautions for Use.) ○ Patients with hepatic impairment: Use of this medicine is not recommended in patients with a history of hepatic impairment who require a reduced dose of losartan (e.g., 25 mg once daily). ○ Older adults: In older adults aged 75 years or older, an initial dose of losartan of 25 mg once daily is recommended; therefore, use of this medicine as initial therapy is not recommended.

Child dose

○ Children: The safety and efficacy of this medicine have not been established in pediatric patients aged 18 years or younger; therefore, its use is not recommended.

Precautions

This medication may cause serious injury or death to the fetus when taken during pregnancy, especially in the second and third trimesters, so it should be immediately discontinued upon confirmation of pregnancy. Hypotension may occur on initial administration in patients with low blood volume, so the underlying condition should be treated first before administration. This medication should not be used in individuals with allergies to specific components, pregnant or breastfeeding women, patients with severe liver dysfunction, severe aortic stenosis, or those in shock. It should be administered cautiously in patients with low blood volume or those requiring strict sodium restrictions, moderate to severe renal impairment, or hyperkalemia. Side effects such as dizziness, headache, drowsiness, dyspepsia, skin rash may occur during use, and if any unusual symptoms develop, a consultation with a physician is advised. When taken with other antihypertensive medications, there may be a potentiation of blood pressure-lowering effects, so caution is needed when co-administered. Taking grapefruit juice may enhance the effects of this medication, so it is better to avoid combining it. Pregnant or breastfeeding women should refrain from taking this medication, and especially during pregnancy, it poses a risk to the fetus, so consultation with a healthcare provider is necessary. Safety and efficacy in patients under 18 have not been established, thus its use is not recommended. Elderly patients, particularly those over 75, need dosage adjustment at initiation; thus, consultation with healthcare providers is required before taking this medication. In case of overdose, severe hypotension or cardiac arrhythmias may occur, so it is important to adhere to the prescribed dosage and inform healthcare professionals immediately in the event of an overdose. This medication should be kept out of the reach of children and should not be transferred to another container for safety. Regular monitoring of blood pressure, kidney function, and serum potassium levels is required while taking this medication.

Side effects

  • Hypotension
  • neonatal skull formation deficiency
  • anuria
  • renal failure
  • oligohydramnios
  • fetal limb contraction
  • craniofacial malformation
  • pulmonary hypoplasia
  • premature
  • intrauterine growth retardation
Show 187 more
  • patent ductus arteriosus
  • dizziness
  • headache
  • drowsiness
  • cerebral infarction
  • weakness
  • chest discomfort
  • chest pain
  • early satiety
  • peripheral edema
  • dependent edema
  • abdominal discomfort
  • dyspepsia
  • nausea
  • gastroesophageal reflux disease
  • constipation
  • pruritus
  • urticaria
  • palpitations
  • flushing
  • orthostatic hypotension
  • facial flushing
  • dyspnea
  • cough
  • dizziness (vertigo)
  • conjunctival injection
  • polyuria
  • fatigue
  • edema
  • vasculitis
  • tension hyperactivity
  • sensory loss
  • paresthesia
  • peripheral neuropathy
  • syncope
  • taste disturbance
  • tremor
  • erectile dysfunction
  • gynecomastia
  • change in bowel habits
  • dry mouth
  • gastritis
  • gingival hypertrophy
  • pancreatitis
  • vomiting
  • hyperglycemia
  • arthralgia
  • low back pain
  • muscle cramps
  • myalgia
  • leukopenia
  • thrombocytopenia
  • insomnia
  • mood changes
  • rhinitis
  • alopecia
  • increased sweating
  • purpura
  • skin pigmentation
  • toxic epidermal necrolysis
  • tinnitus
  • visual disturbances
  • increased urinary frequency
  • urinary dysfunction
  • nocturia
  • hepatitis
  • jaundice
  • elevated liver enzymes
  • pruritus
  • rash
  • angioedema
  • erythema multiforme
  • myocardial infarction
  • arrhythmia
  • abdominal discomfort
  • precordial pain
  • diarrhea
  • soft stools
  • skin erythema
  • erythematous papular rash
  • heaviness
  • warmth
  • impaired glucose tolerance
  • weakness
  • muscle cramps
  • low back pain
  • leg pain
  • congestion
  • upper respiratory tract infection
  • sinusitis
  • sinus disorders
  • pharyngitis
  • myalgia
  • insomnia
  • swelling
  • abdominal pain
  • angioedema
  • skin peeling phenomenon
  • hemolysis
  • facial edema
  • fever
  • orthostatic effects
  • angina
  • second-degree atrioventricular block
  • cerebrovascular accident
  • atrial fibrillation
  • bradycardia
  • tachycardia
  • ventricular tachycardia
  • ventricular fibrillation
  • appetite loss
  • toothache
  • flatulence
  • gastritis
  • anemia
  • gout
  • upper limb pain
  • hip joint pain
  • joint swelling
  • knee pain
  • musculoskeletal pain
  • shoulder pain
  • muscle stiffness
  • arthralgia
  • arthritis
  • fibromyalgia
  • muscle weakness
  • anxiety
  • anxiety disorders
  • ataxia
  • confusion
  • depression
  • nightmares
  • sensory reduction
  • decreased libido
  • memory impairment
  • migraine
  • neurogenic hyperexcitability
  • panic disorder
  • sleep disorder
  • bronchitis
  • pharyngeal discomfort
  • epistaxis
  • rhinitis
  • respiratory congestion
  • alopecia
  • dermatitis
  • dry skin
  • petechial hemorrhage
  • erythema
  • photosensitivity
  • sweating
  • urticaria
  • blurred vision
  • eye burning and pain
  • conjunctivitis
  • taste distortion
  • tinnitus
  • vision loss
  • nocturia
  • urethral infection
  • dry cough
  • angioedema
  • vasculitis
  • anaphylactic reaction
  • hepatic dysfunction
  • intestinal angioedema
  • fatigue
  • thrombocytopenia
  • rhabdomyolysis
  • taste disturbance
  • erythema multiforme
  • hyperkalemia
  • hyponatremia
  • ALT elevation
  • hypotension
  • loss of consciousness
  • acute hepatitis
  • fulminant hepatitis
  • anaphylactic syndrome
  • excessive peripheral vasodilation
  • reflex tachycardia
  • systemic hypotension
  • shock
  • hypotension
  • tachycardia
  • bradycardia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to prevent air and moisture ingress. The recommended storage temperature is room temperature between 1 to 30 degrees Celsius.

Appearance and packaging

Appearance

White rectangular film-coated tablets

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.